Navigation Links
La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert
Date:12/10/2009

business but ADMP does. All LPJC has is NET $3MM in cash and nothing else. As in all reverse mergers, the surviving merged company issues stock to complete the merger. In this merger, regardless of what the market price is, the PPS for LJPC is the $3 million divided by the number of LJPC shares (66 million + 4 million options=70 million). So the most LJPC shares are worth in the merger is about 4-5 cents. LJPC is first performing a reverse stock split to match prices with ADMP. S0 if ADMP is at about 25 cents, its average for the last several months, LJPC shareholders will at least a 5:1 reverse split for the adjusted share price, and get ONE share in the new company. Current ADMP shareholders will also get one share in the company. In the end, LPJC shareholders will only own 10-20% of the company. So at the current LJPC share price, they will see about a NEGATIVE 80% return on their investment... to continue reading the discussion thread visit TapeBeat.Com.

This information was compiled by TapeBeat.Com staff writers with no trading in either stock. TapeBeat.Com is not associated with either company and has received no incentive to disseminate this information, which is the opinion of the poster.

TapeBeat.Com is the place for the serious investor, who wishes to make "Each Trade Better". This is accomplished by a sharing of research and trading strategies with an experienced group of investors. The TapeBeat portfolio is one of the highest ranked on Covestor and is an example of the results that are attainable through the 'free sharing' of information that occurs on TapeBeat.Com. Sign up now to receive important trading alerts for free, or to share your research and opinions.

By viewing information from TapeBeat.Com you agree to our

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. La Jolla Institute for Allergy & Immunology Wows With New Website
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 
(Date:12/24/2014)...   BioLife Solutions , Inc. (NASDAQ: BLFS ), ... hypothermic storage and cryopreservation freeze media ... tissues  ("BioLife" or the "Company"), today announced that it will ... 2015 (the "Annual Meeting"). Because the expected date ...
(Date:12/24/2014)... 23, 2014 Earlier this year in a ... of the Adult Stem Cell Technology Center, LLC ( ASCTC ... unique property of adult tissue stem cells. His title ... Important for the Future,” embodied the essence of his message ...
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ...
(Date:12/24/2014)... expects global cell isolation and expansion market to grow at ... about the vital drivers, restraints, trends, opportunities, strategies and challenges ... http://bit.ly/1yUxy0T , According to the report, the global market ... CAGR during near future. It expects this growth to be ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... reporting system for studying NFAT activation , ... Chao-Feng Zheng ,Stratagene , Stratagenes new PathDetect ... designed for studying the activation of the,nuclear factor ... which play an essential role in inducible gene ...
... of your choice , , ... Inc. , The PathDetect in vivo signal ... the in vivo activation of signal transduction,pathways. ... fusion trans-activator,plasmid that expresses pathway-specific trans-activator proteins ...
... Mycoplasma PCR Primer Set for fast and easy detection ... ,Yale University , D. R. Staggs ,Genetic Applications LLC ... cell cultures can substantially,reduce the potency of transfection reagents. ... the optimal amounts of LipoTAXI ...
Cached Biology Technology:Cis-Reporting System Monitors Intracellular Calcium Mobilization 2Cis-Reporting System Monitors Intracellular Calcium Mobilization 3Cis-Reporting System Monitors Intracellular Calcium Mobilization 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 5New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 2New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 3New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 4New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 5New Fusion Trans-Activator Plasmids for Studying Signal Transduction,Pathways 6Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 2Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection,of Mammalian Cells 3
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ...
(Date:12/11/2014)... Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... addition of the "Biometrics Market in India 2015-2019" ... major trend emerging in this market is the adoption ... than one characteristic of an individual for verification and ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center today ... School of Medicine. Funding for this $50 million capital project ... publicly launched next summer. The medical education ... Reynolds Tobacco Company complex, adjacent to 525@vine in Wake Forest ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... School Team 1 won the Colorado High School Science Bowl ... Bowl in Washington D.C., Apr. 25-29, where they will compete ... 70 high schools. The U.S. Department of Energy (DOE) ... to encourage high school students to explore math and science. ...
... second trimester markers for Down,s syndrome that are detected by ... Ultrasound in Obstetrics & Gynecology , the study,s results ... with the condition. Screening for Down,s syndrome is offered ... risk based on their age. Certain features detected during a ...
... when females choose to mate with more than one ... a team of scientists from Queen Mary, University of London, ... active role in selecting their mates, with a consistent proportion ... males each year. "Until now there has been ...
Cached Biology News:Study reveals significance of second trimester markers for Down's syndrome 2Female deer take control during the mating season 2
... Agarose-HR High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
... Immunogen: Synthetic peptide derived from ... mouse and rat LRP5. ... mouse LRP5 proteins. Reactivity: ... LRP5-pSEC-tag-transfected 293T cells MCF-7 T47D ...
Replacement Parts for Electrophoresis Apparatus...
...
Biology Products: